Syngenis Utilises AI for RNA Therapy Discovery
Perth biotech firm Syngenis is leveraging AI technology to significantly reduce the time and costs associated with discovering RNA therapies. This initiative aims to tap into a rapidly expanding global market that is transforming the landscape of modern medicine.
Read the full story at Sydney Morning Herald→